Market Overview - The medical beauty sector experienced a decline of 0.33% on October 14, with Huaxi Biological leading the drop [1] - The Shanghai Composite Index closed at 3865.23, down 0.62%, while the Shenzhen Component Index closed at 12895.11, down 2.54% [1] Individual Stock Performance - Jinbo Biological (code: 920982) closed at 276.60, up 5.58% with a trading volume of 17,000 shares [1] - *ST Meigu (code: 000615) closed at 3.63, up 4.61% with a trading volume of 326,000 shares [1] - Aimeike (code: 300896) closed at 175.49, down 0.10% with a trading volume of 24,200 shares [1] - Huaxi Biological (code: 688363) closed at 54.02, down 1.15% with a trading volume of 33,100 shares [1] Capital Flow Analysis - The medical beauty sector saw a net inflow of 7.7391 million yuan from main funds, while retail funds experienced a net inflow of 1.0341 million yuan [1] - Speculative funds had a net outflow of 8.7732 million yuan [1] Detailed Capital Flow for Individual Stocks - Aimeike had a net outflow of 9.3340 million yuan, down 2.20% [2] - *ST Meigu experienced a net inflow of 1.1847 million yuan, up 1.03% [2] - Huaxi Biological had a significant net outflow of 10.6702 million yuan, down 5.90% [2]

Group 1 - The medical beauty sector experienced a decline of 1.92% on October 13, with Ai Meike leading the drop [1] - The Shanghai Composite Index closed at 3889.5, down 0.19%, while the Shenzhen Component Index closed at 13231.47, down 0.93% [1] - Major stocks in the medical beauty sector showed mixed performance, with *ST Meigu rising by 5.15% to a closing price of 3.47, while Ai Meike fell by 2.32% to 175.66 [1] Group 2 - The net outflow of main funds in the medical beauty sector was 75.6993 million yuan, while retail investors saw a net inflow of 48.3038 million yuan [1] - Specific fund flows for major stocks indicated that Ai Meike had a net outflow of 51.1050 million yuan, representing a decrease of 10.15% [2] - Huaxi Biological and *ST Meigu also experienced significant net outflows of 15.8278 million yuan and 8.7665 million yuan, respectively [2]

证券代码：000615 证券简称：*ST美谷 公告编号：2025-082 奥园美谷科技股份有限公司 关于预重整事项进展暨召开第一次临时债权人会议的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有 虚假记载、误导性陈述或重大遗漏。 重要风险提示： 1.公司已进入预重整程序，公司能否进入重整程序尚存在不确定性。 预重整程序是为了提前启动公司债权债务梳理等相关工作，提高后续重整 工作推进效率及重整可行性的程序。襄阳中院同意公司预重整，不代表法院正 式受理申请人对公司的重整申请，截至本公告披露日，公司尚未收到法院关于 受理重整申请的相关法律文书，即申请人的重整申请能否被法院受理、公司后 续能否进入重整程序均存在不确定性。敬请广大投资者注意投资风险。 重整或预重整是否成功也存在不确定性。法院决定受理预重整申请，也不 代表公司正式进入重整程序。如果公司预重整成功，法院将依法审查是否受理 重整申请，公司能否进入重整程序尚存在不确定性。敬请广大投资者注意投资 风险。 2.法院受理重整申请后，公司股票交易存在被实施退市风险警示的风险。 根据《深圳证券交易所股票上市规则（2025 年修订）》（以下简称《股票 ...

奥园美谷科技股份有限公司 预重整方案 二〇二五年十月 | | | | 十一、其他事项 34 | | --- | 释 义 除非本预重整方案中另有明确所指，下列词语的含义为： | 简称 | | 词语含义或全称 | | --- | --- | --- | | 奥园美谷/债务人/ | 指 | 奥园美谷科技股份有限公司 | | 公司 | | | | 襄阳中院 | 指 | 襄阳市中级人民法院 | | 临时管理人 | 指 | 由襄阳中院指定的奥园美谷科技股份有限公司临时 | | | | 管理人 | | 管理人 | 指 | 在襄阳中院裁定受理广州律建对奥园美谷的重整申 | | | | 请后，所指定的奥园美谷科技股份有限公司管理人 | | 奥园科星/控股股 | 指 | 深圳奥园科星投资有限公司 | | 东 | | | | 中国奥园 | 指 | 中国奥园集团股份有限公司 | | 京汉控股/前任控 | 指 | 京汉控股集团有限公司 | | 股股东 | | | | 前任控股股东及 | 指 | 前任控股股东京汉控股及其一致行动人北京合力万 | | 其一致行动人 | | 通信息咨询中心（有限合伙）、段亚娟 | | 广州律建 | 指 | ...

Market Overview - The medical beauty sector experienced a decline of 0.5% on October 10, with Jinbo Biological leading the drop [1] - The Shanghai Composite Index closed at 3897.03, down 0.94%, while the Shenzhen Component Index closed at 13355.42, down 2.7% [1] Stock Performance - The following stocks in the medical beauty sector showed varying performance: - *ST Meigu (000615)*: Closed at 3.30, down 0.30% with a trading volume of 64,200 shares [1] - Aimeike (300896): Closed at 179.84, down 0.32% with a trading volume of 27,000 shares [1] - Huaxi Biological (688363): Closed at 55.78, down 0.76% with a trading volume of 38,500 shares [1] - Jinbo Biological (920982): Closed at 267.48, down 1.95% with a trading volume of 9,733 shares [1] Capital Flow - The medical beauty sector saw a net inflow of 14.16 million yuan from main funds, while retail funds experienced a net outflow of 8.85 million yuan [1] - Detailed capital flow for specific stocks includes: - Aimeike (300896): Net outflow of 11.73 million yuan, down 2.40% [2] - *ST Meigu (000615)*: Net outflow of 1.17 million yuan, down 5.51% [2] - Huaxi Biological (688363): Net outflow of 3.72 million yuan, down 1.72% [2]

Core Viewpoint - *ST Meigu's subsidiary, Jinhua Green Fiber, failed to repay approximately 212 million yuan in debt, leading to the judicial auction of real estate assets by Jinghan Real Estate Group [1][2] Group 1: Legal and Financial Developments - On October 9, *ST Meigu announced significant litigation progress regarding its subsidiary Jinhua Green Fiber's failure to repay debt [1] - The debt originated from a fixed asset loan agreement signed in January 2020, with a repayment plan adjusted in March 2023 [1] - The Xiangyang Intermediate People's Court issued an execution notice demanding Jinhua Green Fiber repay a principal amount of 187,507,905.75 yuan, along with interest and penalties totaling approximately 27.14 million yuan by March 7, 2025 [1] Group 2: Auction Details - The real estate assets of Jinghan Real Estate will be auctioned on October 26, 2025, with a starting price of 154,380,000 yuan [2] - The auction results are uncertain, and if Jinghan Real Estate assumes the guarantee responsibility, it may reduce the liability amounts for other guarantors [2] - *ST Meigu will continue to monitor the litigation progress and disclose updates accordingly [2]

证券代码：000615 证券简称：*ST美谷 公告编号：2025-081 奥园美谷科技股份有限公司 关于重大诉讼进展的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有 虚假记载、误导性陈述或重大遗漏。 特别提示： 1、案件所处的诉讼阶段：执行； 2、上市公司所处的当事人地位：被告（担保方）； 3、对上市公司损益产生的影响：本次诉讼对公司本期利润或期后利润的具 体影响需结合实际执行等情况而确定，会计处理及财务数据以审计机构年度审计 确认的结果为准。敬请广大投资者注意投资风险。 一、本次诉讼的基本情况 2020 年 1 月，奥园美谷科技股份有限公司（以下简称"奥园美谷"、"公 司"）控股子公司湖北金环绿色纤维有限公司（以下简称"金环绿纤"）与中国 银行股份有限公司襄阳分行（以下简称"中行襄阳分行"）签订了《固定资产借 款合同》，同时中行襄阳分行分别与京汉置业集团有限责任公司（以下简称"京 汉置业"）、金环绿纤签订《抵押合同》，京汉置业、金环绿纤为前述《固定资 产借款合同》及其修订或补充协议提供抵押担保。公司及其控股子公司湖北金环 新材料科技股份有限公司（以下简称"金环新材料"）、田汉、李莉分别 ...

Core Insights - The medical beauty sector experienced a slight increase of 0.18% on October 9, with Huaxi Biological leading the gains [1] - The Shanghai Composite Index closed at 3933.97, up 1.32%, while the Shenzhen Component Index closed at 13725.56, up 1.47% [1] Medical Beauty Sector Performance - Huaxi Biological (688363) closed at 56.21, with a rise of 1.43% and a trading volume of 40,100 shares [1] - Aimeike (300896) closed at 180.42, down 0.62% with a trading volume of 29,300 shares [1] - ST Meigu (000615) closed at 3.31, down 0.90% with a trading volume of 124,000 shares [1] - Jinbo Biological (920982) closed at 272.80, down 3.12% with a trading volume of 10,000 shares [1] Capital Flow Analysis - The medical beauty sector saw a net outflow of 44.2015 million yuan from main funds and a net outflow of 32.526 million yuan from speculative funds, while retail investors had a net inflow of 76.7274 million yuan [1] - Huaxi Biological had a main fund net inflow of 5.4613 million yuan, accounting for 2.45% of its total [2] - Aimeike experienced a significant main fund net outflow of 47.1115 million yuan, representing 8.95% of its total [2] - ST Meigu had a main fund net outflow of 2.5512 million yuan, accounting for -6.23% of its total [2]

Core Insights - The medical beauty sector experienced a slight increase of 0.15% on September 30, with *ST Meigu leading the gains [1] - The Shanghai Composite Index closed at 3882.78, up 0.52%, while the Shenzhen Component Index closed at 13526.51, up 0.35% [1] Sector Performance - The closing prices and performance of key stocks in the medical beauty sector are as follows: - *ST Meigu (000615) closed at 3.34, up 1.83% with a trading volume of 122,900 shares and a turnover of 41.15 million yuan [1] - Huaxi Biological (688363) closed at 55.42, up 0.73% with a trading volume of 29,800 shares and a turnover of 164 million yuan [1] - Aimeike (300896) closed at 181.55, down 0.36% with a trading volume of 24,000 shares and a turnover of 43.5 million yuan [1] - Jinbo Biological (832982) closed at 281.59, down 0.95% with a trading volume of 5,375 shares and a turnover of 152 million yuan [1] Capital Flow - The medical beauty sector saw a net outflow of 23.11 million yuan from institutional investors, while retail investors contributed a net inflow of 31.04 million yuan [1] - Detailed capital flow for key stocks indicates: - Huaxi Biological experienced a net outflow of 9.59 million yuan, down 5.83% [2] - *ST Meigu had a net outflow of 1.25 million yuan, down 3.03% [2] - Aimeike faced a significant net outflow of 34.29 million yuan, down 7.89% [2]

证券之星消息，9月29日医疗美容板块较上一交易日上涨0.36%，华熙生物领涨。当日上证指数报收于 3862.53，上涨0.9%。深证成指报收于13479.43，上涨2.05%。医疗美容板块个股涨跌见下表： | 代码 | 名称 | 收盘价 | 涨跌幅 | 成交量(手) | 成交额(元) | | --- | --- | --- | --- | --- | --- | | 688363 | 华熙生物 | 55.02 | 0.86% | 2.61万 | 1.42亿 | | 000615 | *ST美谷 | 3.28 | 0.61% | 12.38万 | 4002.69万 | | 300896 | 爱美客 | 182.20 | -0.01% | 2.67万 | 4.81亿 | | 832982 | 锦波生物 | 284.30 | -0.65% | 4900.44 | 1.40亿 | | 代码 | | | 名称 主力净流入（元） 主力净占比 游资净流入（元） 游资净占比 散户净流入（元） 散户净占比 | | | | | --- | --- | --- | --- | --- | --- | --- | | 688363 ...